Effects of hypoxia on drug resistance phenotype and genotype in human glioma cell lines

Journal of Neuro-Oncology

Volumn 29, Issue 2, 1996, Pages 149-155

  Liang, Bertrand C ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

BCNU; Cis platinum; Drug therapy; Glioblastoma

Indexed keywords

CARMUSTINE; CISPLATIN;

ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; DRUG RESISTANCE; GENE; GENE EXPRESSION; GENOTYPE; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HYPOXIA; MULTIDRUG RESISTANCE; PHENOTYPE;

EID: 0030056563     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00182138     Document Type: Article

References (41)

1. Walker AE, Robins M, Weinfeld FD: Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology 35: 219-226, 1985
2. Walker MD, Green SB, Byar DP, Alexander E, Betzdorf U, Brooks WH, Hunt WE, MacCarty M: Randomized comparisons of radiotherapy and nitrosureas for the treatment of malignant gliomas after surgery. New Eng J Med 303: 1323-1329, 1980
3. Feun LG, Savaraj N, Landy H: Drug resistance in brain tumors. J Neurone 20: 165-176, 1994
4. Endicott JA, Ling V: The biochemistry of P-Glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58: 137-171, 1989
5. Cole SPC, Nhardaj C, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV, Deeley RG: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654, 1992
6. Rosenblum ML, Gerosa MA, Bodell WJ, Talcott RL: Tumor cell resistance. In: Progress in Experimental Research, Volume 27, pp 191-211. Karger Publishers, Basel 1984
7. Dabholkar M, Vionnet J, Bostick-Bruton F, Yu JJ, Reed E: Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate to response to platinum based chemotherapy. J Clin Invest 94: 703-708, 1994
8. Dabholkar M, Bostick-Bruton R, Reed E: ERCC1 and ERCC2 expression in fresh human tumor tissues. J Natl Cancer Inst 84: 1512-1517, 1992
9. Teicher BA: Hypoxia and drug resistance. Canc Metas Rev 13: 139-168, 1994
10. Shapiro WR, Shapiro JR: Principles of brain tumor chemotherapy. Semin Oncol 13: 56-69, 1986
11. Teicher BA, Waxman DJ, Holden SA, Wang Y, Clarke L, Alvarez Sotomayor E, Jones SM, Frei E: Evidence for enzymatic activation and oxygen involvement in cytotoxicity and antitumor activity of N, N′, N″-triethylenethiophosphoramide. Cancer Res 49: 4996-5001, 1989
12. Rice GC, Ling V, Shimke RT: Frequencies of independent and simultaneous selection of Chinese hamster cells for methotrexate and doxorubicin (adriamycin) resistance. Proc Natl Acad Sci 84: 9261-9264, 1987
13. Schlappack OK, Zimmermann A, Hill RP: Glucose starvation and acidosis: effect on experimental metastatic potential, DNA content and MTX resistance of murine tumor cells. Br J Cancer 64: 663-670, 1991
14. Wilson RE, Keng PC, Sutherland RM: Drug resistance in Chinese hamster ovary cells during recovery from severe hypoxia. J Natl Cancer Inst 81: 1235-1240, 1989
15. Wilson RE, Talley RD, Storch TG: Oxygen concentration regulated EGF-induced proliferation and EGFR down regulation. Biochim Biophys Res Commun 153: 952-958, 1988
16. Deguchi Y, Negoro S, Kishimoto S: c-fos expression in human skin fibroblasts by reperfusion after oxygen deficiency: a recovery change of human skin fibroblasts after oxygen deficiency stress. Biochim Biophys Res Commun 149: 1093-1098, 1987
17. Young SD, Hill RP: Effects of reoxygenation of cells from hypoxic regions of solid tumors: anticancer drug sensitivity and metastatic potential. J Natl Cancer Inst 82: 371-380, 1990
18. Rice GC, Hoy C, Schimke RT: Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc Natl Acad Sci 83: 5978-5982, 1986
19. Nakatsu Y, Hattori K, Hayakawa H, Shimizu K, Sekiguchi M: Organization and expression of the human gene for 06, m-methylguanine-DNA methyltransferase. Mut Res 293: 119-132, 1993
20. Heacock CS, Sutherland RM: Enhanced synthesis of stress proteins caused by hypoxia and relation to altered cell growth and metabolism. Br J Cancer 62: 217-225, 1990
21. Sciandra JJ, Subjeck JR, Hughes CS: Induction of glucose-regulated proteins during anaerobic exposure and of heatshock proteins after reoxygenation. Proc Natl Acad Sci 81: 4843-4847, 1984
22. Brown JM, Giaccia AJ: Tumor hypoxia: the picture has changed in the 1990s. Int J Radiat Biol 65: 95-102, 1994
23. Yao KS, Clayton M, O'Dwyer PJ: Interaction of head and hypoxia modulating transcription of DT diaphorase in human colon adenocarcinoma cells. Cell Growth Differ 5: 125-131, 1994
24. Shapiro WR: Therapy of adult malignant brain tumors: What have the clinical trials taught us? Semin Oncol 13: 38-45, 1986
25. Nyce J: Drug-induced DNA hypermethylation and drug resistance in human tumors. Canc Res 49: 5829-5836, 1989
26. Bentivegna SS, Bresnick E: Inhibition of human 06-methylguanine-DNA methyltransferase by 5-methylcytosine. Canc Res 54: 327-329, 1994
27. Sakata K, Tak Kwok T, Murphy BJ, Laderoute KR, Gordon GR, Sutherland RM: Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance. Br J Cancer 64: 809-814, 1991
28. Bodell WJ, Tokuda K, Ludlum DB: Differences in DNA alkylation products formed in sensitive and resistant human glioma cells treated with N-(2-chloroethyl)-1-nitrosurea. Canc Res 48: 4489-4492, 1988
29. Hill DL, Kirk MC, Struck RF: Microsomal metabolism of nitrosureas. Canc Res 35: 296-301, 1975
30. Hill DL, N,N′-bis(2-chloroethyl)-N-nitrosurea, a substrate for glutathione (GSH) S-transferase. Proc Am Assoc Canc Res 17: 52, 1976
31. Talcott RE, Levin VA: Glutathione-dependent denitrosation of BCNU: Nitrite release catalyzed by mouse liver cytosol in vitro. Drug Metab Disappos 11: 175-176, 1983
32. Smith MT, Evans CG, Doane-Setzar P, Castro VM, Tahir MK, Mannervik B: Dentrosation of 1, 3-bis(2-chloroethyl) 1-nitrosurea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells. Canc Res 49: 2621-2625, 1989
33. Montaudon D, Bencherkroun MN, Londos-Gagliardi D, Robert J: Chromosomal modifications of a rat glioblastoma cell line during the acquisition and reversal of doxorubicin resistance. Anticanc Res 10: 1667-1676, 1990
34. Liang BC, Ross DA, Reed E: Genomic copy number changes of DNA repair genes ERCC1 and ERCC2 in human gliomas. J Neuroonc, 26: 17-23 1995
35. Matsumoto T, Tani E, Kaba K, Kochi N, Shindo H, Miyaji K: Amplification and expression of a multidrug resistance gene in human glioma cell line. J Neurosurg 72: 96-101, 1990
36. Nabors MW, Griffin CA, Zehnbauer BA, Hruban RH, Phillips PC, Grossman SA, Brem H, Colvin OM: Multdrug resistance gene (MDR1) expression in human brain tumors. J Neurosurg 75: 941-946, 1991
37. Abe T, Hasegawa S, Taniguchi K, Yokomizo A, Kuwano T, Ono M, Mori T, Hori S, Kohno K, Kuwano M: Possible involvement of multidrug-resistance associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide, and adriamycin in human glioma cells. Int J Canc 58: 860-864, 1994
38. Simon S, Roy D, Shindler M: Intracellular pH and the control of multidrug resistance. Proc Natl Acad Sci 91: 1128-1132, 1994
39. Schneider E, Altenberg GA, Cowen K: Increased intracellular pH as a possible mechanism of MRP-mediated multidrug resistance in the human mammary carcinoma cell line MCF7/VP. Proc Am Assoc Canc Res 36: 325, 1995
40. Bougnoux P, Chajes V, Hubert B, Germain E, Lhuillery C, Saez S, Calais G: n-3 polyunsaturated fatty acids and chemosensitivity of breast carcinoma. Proc Am Assoc Canc Res 36: 327, 1995
41. Owen R, Andrews PA, Murphy MP: Significant differences in DNA-binding proteins purified from MCF-7 adriamycin resistant versus sensitive breast carcinoma cell lines. Proc Am Assoc Canc Res 36: 327, 1995